{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:10:07Z","timestamp":1790021407739,"version":"4.0.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.cpet.2014.03.008","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T15:15:15Z","timestamp":1398525315000},"page":"323-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The Use of Gallium-68 Labeled Somatostatin Receptors in PET\/CT Imaging"],"prefix":"10.1016","volume":"9","author":[{"given":"Valentina","family":"Ambrosini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpet.2014.03.008_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.cpet.2014.03.008_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1536-1632(03)00038-6","article-title":"Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D-Phe1-Tyr3-octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors","volume":"5","author":"Kowalski","year":"2003","journal-title":"Mol Imaging Biol"},{"issue":"10","key":"10.1016\/j.cpet.2014.03.008_bib3","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","article-title":"Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours","volume":"34","author":"Buchmann","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.cpet.2014.03.008_bib4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","article-title":"Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?","volume":"34","author":"Antunes","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2014.03.008_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.cpet.2014.03.008_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in\u00a0vivo multireceptor tumour targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2014.03.008_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J\u00a0Nucl Med"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2014.03.008_bib8","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1007\/s00259-011-1989-4","article-title":"68Ga-labelled SSTRTs for diagnosis of gastroenteropancreatic NET","volume":"39","author":"Ambrosini","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.cpet.2014.03.008_bib9","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","article-title":"Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA-conjugated SSTRTs: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE","volume":"37","author":"Virgolini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.cpet.2014.03.008_bib10","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.2967\/jnumed.111.091165","article-title":"68Ga-DOTATOC\u00a0versus 68Ga-DOTATATE PET\/CT in functional imaging of neuroendocrine tumors","volume":"52","author":"Poeppel","year":"2011","journal-title":"J\u00a0Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2014.03.008_bib11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00259-012-2123-y","article-title":"Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET\/CT imaging in the same patient group with neuroendocrine tumours","volume":"39","author":"Kabasakal","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2014.03.008_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.109.066134","article-title":"The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy","volume":"51","author":"Srirajaskanthan","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2014.03.008_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2967\/jnumed.109.071712","article-title":"68Ga-DOTANOC\u00a0PET\/CT clinical impact in patients with neuroendocrine tumors","volume":"51","author":"Ambrosini","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"3","key":"10.1016\/j.cpet.2014.03.008_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2967\/jnumed.109.066662","article-title":"Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors","volume":"51","author":"Campana","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2014.03.008_bib15","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00259-011-1846-5","article-title":"Molecular imaging with 68Ga-SSTR PET\/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours","volume":"38","author":"Kaemmerer","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.cpet.2014.03.008_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00259-009-1205-y","article-title":"Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET\/CT","volume":"37","author":"Prasad","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.cpet.2014.03.008_bib17","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00259-008-0769-2","article-title":"Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuroendocrine tumours","volume":"35","author":"Ambrosini","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2014.03.008_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00259-008-1030-8","article-title":"Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours","volume":"36","author":"Haug","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.cpet.2014.03.008_bib19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.critrevonc.2009.02.009","article-title":"Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results","volume":"71","author":"Koopmans","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cpet.2014.03.008_bib20","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1021\/bc030078f","article-title":"Microwave-supported\u00a0preparation of 68Ga bioconjugates with high specific radioactivity","volume":"15","author":"Velikyan","year":"2004","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.cpet.2014.03.008_bib21","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00259-004-1486-0","article-title":"68Ga-labelled DOTA-derivatised peptide ligands","volume":"31","author":"Meyer","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2014.03.008_bib22","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2967\/jnumed.107.040378","article-title":"Processing of generator-produced 68Ga for medical application","volume":"48","author":"Zhernosekov","year":"2007","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2014.03.008_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00259-004-1702-y","article-title":"Radiolabelling DOTA-SSTRTs with 68Ga","volume":"32","author":"Breeman","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2014.03.008_bib24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/MNM.0b013e3282f1753d","article-title":"A\u00a0fully automated synthesis for the preparation of 68Ga-labelled SSTRTs","volume":"28","author":"Decristoforo","year":"2007","journal-title":"Nucl Med Commun"},{"issue":"4","key":"10.1016\/j.cpet.2014.03.008_bib25","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s00330-011-2328-7","article-title":"Are contrast media required for (68)Ga-DOTATOC PET\/CT in patients with neuroendocrine tumours of the abdomen?","volume":"22","author":"Mayerhoefer","year":"2012","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.cpet.2014.03.008_bib26","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2967\/jnumed.111.088328","article-title":"Incidence of increased 68Ga-DOTANOC uptake in the pancreatic head in a large series of extrapancreatic NET patients studied with sequential PET\/CT","volume":"52","author":"Castellucci","year":"2011","journal-title":"J\u00a0Nucl Med"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859814000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859814000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T11:53:40Z","timestamp":1538654020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859814000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1556859814000352"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2014.03.008","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Gallium-68 Labeled Somatostatin Receptors in PET\/CT Imaging","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2014.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}